Know someone doing exceptional work? The Cytokine Society Young Investigator Awards, including the Regeneron New Investigator Awards, Christina Fleischmann Award for Excellence, Amanda Proudfoot Award, Pfizer Trainee Awards, and the Sidney and Joan Pestka Graduate and Post-Graduate Awards celebrate emerging researchers who show exceptional promise. Winners gain opportunities to present [READ MORE]
The Cytokine Society Nominating Committee is looking for engaged members ready to step into leadership. We’re accepting nominations for the following positions: Secretary — Officer of the Corporation; two-year term beginning October 2026 Two (2) Council Members — three-year terms beginning January 2027 One (1) Council Member for Inclusion and [READ MORE]
My name is Gabrielle Belz, and I am currently a Professor, Laureate Fellow and Group Leader at the Frazer Institute, The University of Queensland, Australia. My research focuses on how different types of immune cells develop and generated long-term immune protection or memory, and now we have a major emphasis [READ MORE]
Dr. María M Caffarel is an Ikerbasque Researcher at the Biogipuzkoa Health Research Institute (formerly known as Biodonostia) in San Sebastian (Spain) where she leads the Breast Cancer group within the Oncology Area. Her team’s main focus is the study of the molecular mechanisms involved in breast cancer progression, with [READ MORE]
When laboratories closed and conferences were cancelled during the early months of the COVID19 pandemic, the scientific world abruptly lost the informal conversations and seminar exchanges that fuel collaboration and new ideas. To mitigate these effects in the fungal research community, a small group of researchers created an online seminar [READ MORE]
Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL (APL) ClinicalTrials.gov ID NCT06450145 Sponsor Zhejiang Provincial People’s Hospital Information provided by Zhejiang Provincial People’s Hospital (Responsible Party Brief Summary This study was a single-arm, open study. After the screening period, arsenic-resistant APL patients [READ MORE]
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT ClinicalTrials.gov ID NCT06130579 Sponsor Peking University People’s Hospital Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party) Last Update Posted 2025-06-03 Brief Summary To investigate the efficacy of interferon-α prophylaxis in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) [READ MORE]
Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study (INCAS) ClinicalTrials.gov ID NCT05653193 Sponsor Manchester University NHS Foundation Trust Information provided by Manchester University NHS Foundation Trust (Responsible Party) Last Update Posted 2025-03-03 Brief Summary This study explores the role of treatment with interferon-gamma to improve outcomes [READ MORE]
A recent study by Alharbi et.al. from the Gantier Lab published in Nature Immunology, “2′-O-Methyl-guanosine RNA fragments antagonize TLR7 and TLR8 to limit autoimmunity”, showed that TLR7 and TLR8 sensing is kept in check by naturally occurring 2′-O-methyl (2′-OMe)-modified ribosomal RNA fragments, avoiding autoimmune responses to host RNA in the [READ MORE]
I am an associate professor at Rutgers University in New Jersey, and I’m on a mission to decode the conversation between CD4+ T cells and B cells. These T cells use cytokines as their messages, and I am particularly fascinated by the cytokines secreted by a subset of these T [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
